It has been proposed that two distinct signals are required for the triggering of the precursors of antibody-forming bone marrow-derived cells (B cells): (a) the binding of antigen or of a mitogen to the corresponding receptor sites on B-cell membranes and (b) the interaction of activated C3 with the C3 receptor of B lymphocytes. There is growing evidence that B-cell mitogens and T (thymus-derived cell)-independent antigens are capable of activating the alternate pathway of the complement system (bypass). Therefore, the effect of another potent bypass inducer was investigated with regard to B-cell activation and the role of C3. Purified, pyrogen-free cobra venom factor was mitogenic for both T and B lymphocytes (cortisone-resistant mouse thymus cells and lymph node lymphocytes from congenitally athymic mice). Venom factor could substitute for T cells by restoring the potential of antibody formation to sheep red blood cells in mouse B-cell cultures supplemented with macrophages or 2-mercaptoethanol. Venom factor may be capable of conferring activated C3 to the C3 receptor of B lymphocytes: preincubation of lymphoid cells with homologous serum or plasma, 10 mM EDTA, and sepharose-coupled venom factor converted with serum to an enzyme active against C3, inhibited their capacity to subsequently form rosettes with sheep erythrocytes sensitized with amboceptor and C5-deficient mouse complement. In the absence of EDTA, preincubation of freshly prepared B-cell suspensions with C3-sufficient homologous serum also blocked their subsequent interaction with complement-sensitized erythrocytes and at the same time rendered them reactive to an otherwise T-cell-specific mitogen. Moreover, mitogen induced B-cell proliferation in lymph node (but not in spleen) cell cultures, appeared to depend on the availability of exogenous C3: zymosan-absorbed fetal bovine serum (only 8.3% site-forming units remaining) supported T-cell activation by phytohemagglutinin, concanavalin A, and venom factor, but failed to sustain B-cell stimulation by pokeweed mitogen, lipopolysaccharide, and venom factor. T-cell-dependent antibody formation in composite cultures containing T cells or T-cell-substituting B-cell mitogens, B cells, and macrophages, always required the presence of C3-sufficient serum.
Skip Nav Destination
Article navigation
1 February 1974
Article|
February 01 1974
COMPLEMENT-DEPENDENT B-CELL ACTIVATION BY COBRA VENOM FACTOR AND OTHER MITOGENS?
Peter Dukor,
Peter Dukor
From the Research Department, Pharmaceuticals Division, CIBA-GEIGY Limited, CH-4002 Basle, Switzerland and the Institut für Medizinische Mikrobiologie der Johannes-Gutenberg-Universität, D-65 Mainz, Germany
Search for other works by this author on:
Gebhard Schumann,
Gebhard Schumann
From the Research Department, Pharmaceuticals Division, CIBA-GEIGY Limited, CH-4002 Basle, Switzerland and the Institut für Medizinische Mikrobiologie der Johannes-Gutenberg-Universität, D-65 Mainz, Germany
Search for other works by this author on:
Roland H. Gisler,
Roland H. Gisler
From the Research Department, Pharmaceuticals Division, CIBA-GEIGY Limited, CH-4002 Basle, Switzerland and the Institut für Medizinische Mikrobiologie der Johannes-Gutenberg-Universität, D-65 Mainz, Germany
Search for other works by this author on:
Manfred Dierich,
Manfred Dierich
From the Research Department, Pharmaceuticals Division, CIBA-GEIGY Limited, CH-4002 Basle, Switzerland and the Institut für Medizinische Mikrobiologie der Johannes-Gutenberg-Universität, D-65 Mainz, Germany
Search for other works by this author on:
Wolfgang König,
Wolfgang König
From the Research Department, Pharmaceuticals Division, CIBA-GEIGY Limited, CH-4002 Basle, Switzerland and the Institut für Medizinische Mikrobiologie der Johannes-Gutenberg-Universität, D-65 Mainz, Germany
Search for other works by this author on:
Ulrich Hadding,
Ulrich Hadding
From the Research Department, Pharmaceuticals Division, CIBA-GEIGY Limited, CH-4002 Basle, Switzerland and the Institut für Medizinische Mikrobiologie der Johannes-Gutenberg-Universität, D-65 Mainz, Germany
Search for other works by this author on:
Dieter Bitter-Suermann
Dieter Bitter-Suermann
From the Research Department, Pharmaceuticals Division, CIBA-GEIGY Limited, CH-4002 Basle, Switzerland and the Institut für Medizinische Mikrobiologie der Johannes-Gutenberg-Universität, D-65 Mainz, Germany
Search for other works by this author on:
Peter Dukor
From the Research Department, Pharmaceuticals Division, CIBA-GEIGY Limited, CH-4002 Basle, Switzerland and the Institut für Medizinische Mikrobiologie der Johannes-Gutenberg-Universität, D-65 Mainz, Germany
Gebhard Schumann
From the Research Department, Pharmaceuticals Division, CIBA-GEIGY Limited, CH-4002 Basle, Switzerland and the Institut für Medizinische Mikrobiologie der Johannes-Gutenberg-Universität, D-65 Mainz, Germany
Roland H. Gisler
From the Research Department, Pharmaceuticals Division, CIBA-GEIGY Limited, CH-4002 Basle, Switzerland and the Institut für Medizinische Mikrobiologie der Johannes-Gutenberg-Universität, D-65 Mainz, Germany
Manfred Dierich
From the Research Department, Pharmaceuticals Division, CIBA-GEIGY Limited, CH-4002 Basle, Switzerland and the Institut für Medizinische Mikrobiologie der Johannes-Gutenberg-Universität, D-65 Mainz, Germany
Wolfgang König
From the Research Department, Pharmaceuticals Division, CIBA-GEIGY Limited, CH-4002 Basle, Switzerland and the Institut für Medizinische Mikrobiologie der Johannes-Gutenberg-Universität, D-65 Mainz, Germany
Ulrich Hadding
From the Research Department, Pharmaceuticals Division, CIBA-GEIGY Limited, CH-4002 Basle, Switzerland and the Institut für Medizinische Mikrobiologie der Johannes-Gutenberg-Universität, D-65 Mainz, Germany
Dieter Bitter-Suermann
From the Research Department, Pharmaceuticals Division, CIBA-GEIGY Limited, CH-4002 Basle, Switzerland and the Institut für Medizinische Mikrobiologie der Johannes-Gutenberg-Universität, D-65 Mainz, Germany
Received:
August 31 1973
Online ISSN: 1540-9538
Print ISSN: 0022-1007
Copyright © 1974 by The Rockefeller University Press
1974
J Exp Med (1974) 139 (2): 337–354.
Article history
Received:
August 31 1973
Citation
Peter Dukor, Gebhard Schumann, Roland H. Gisler, Manfred Dierich, Wolfgang König, Ulrich Hadding, Dieter Bitter-Suermann; COMPLEMENT-DEPENDENT B-CELL ACTIVATION BY COBRA VENOM FACTOR AND OTHER MITOGENS? . J Exp Med 1 February 1974; 139 (2): 337–354. doi: https://doi.org/10.1084/jem.139.2.337
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement